Tandem Diabetes Care, Inc. TNDM
15.72
0.50
3.29%
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow TNDM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (48.03%) | (65.73%) | (97.88%) | (109.73%) |
+8 more TTM periods Free account |
|
| (6.24%) | (9.11%) | (22.15%) | (22.20%) | ||
ROIC |
(10.33%) | (31.96%) | (67.83%) | (99.30%) | |
Return on Tangible Assets |
(9.95%) | (13.09%) | (44.60%) | (45.98%) | |
Average Days of Receivables |
56.80 | 49.97 | 59.53 | 45.65 | |
Free Cash Flow per Share |
(0.39) | (0.05) | (0.44) | (0.37) | |
Free Cash Flow |
(26.62) | (3.64) | (29.67) | (25.12) | |
Capital Expenditures |
(21.09) | (23.25) | (19.95) | (16.33) | |
Piotroski F-Score |
4.00 | 5.00 | 3.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(0.46%) | 1.50% | (1.28%) | (1.15%) | |
Accounts Receivable Turnover |
7.17 | 7.69 | 7.25 | 8.64 | |
Accounts Payable Turnover |
7.64 | 7.74 | 10.21 | 9.79 | |
Inventory Turnover |
3.30 | 3.46 | 3.37 | 3.25 | |
Average Days of Payables |
51.10 | 47.18 | 36.65 | 36.80 | |
Days of Inventory on Hand |
107.65 | 99.62 | 100.27 | 106.39 | |
Tax Rate |
0.04 | (0.04) | 0.02 | (0.01) | |
Research and Development Expense of Revenue |
18.03% | 18.39% | 26.44% | 27.26% | |
Selling, General and Administrative Expense of Revenue |
42.38% | 42.76% | 43.85% | 43.47% | |
Share Based Compensation of Revenue |
6.98% | 8.03% | 9.10% | 9.97% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.09 | (0.21) | 0.05 | 0.04 | |
Depreciation/Fixed assets |
0.19 | 0.20 | 0.19 | 0.20 | |
Capex/Depreciation |
(1.29) | (1.42) | (1.27) | (1.05) | |
Revenue per Share |
15.09 | 15.02 | 15.08 | 14.89 | |
Operating CF per Share |
(0.08) | 0.29 | (0.14) | (0.13) | |
Capex per Share |
(0.31) | (0.34) | (0.30) | (0.24) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
(6.08%) | (9.20%) | (20.17%) | (20.20%) |
Columns are period end dates